- Home
- NKX vs CRMD Comparison
NKX vs CRMD Comparison
Compare NKX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKX | CRMD |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 613.8M | 876.7M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | NKX | CRMD |
|---|---|---|
| Price | $12.73 | $10.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $17.43 |
| AVG Volume (30 Days) | 109.3K | ★ 3.1M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $565.64 |
| Revenue Next Year | N/A | $46.09 |
| P/E Ratio | ★ N/A | $4.34 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $9.78 | $5.60 |
| 52 Week High | $12.00 | $17.43 |
Technical Indicators
Market Signals| Indicator | NKX | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 46.49 |
| Support Level | $12.74 | $9.20 |
| Resistance Level | $12.82 | $9.88 |
| Average True Range (ATR) | 0.06 | 0.56 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 15.79 | 35.36 |
Price Performance
Historical ComparisonAbout NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.